Skip to the main content.


GlycoSeLect Announces Investment & Development Partnership with KBI Biopharma

15th August, 2016. Equity investment in initial funding round, license agreement and development project. Dublin, Ireland & Durham, North Carolina, USA

Read More

JSR Corporation and KBI Biopharma, Inc. Agree to Acquisition; INCJ and CMIC of Japan also participate

Sunnyvale, CA and Tokyo, Japan – February 26, 2015 – JSR Corporation (JSR), along with Tokyo-based CMIC Holdings Co. Ltd. (CMIC) and Innovation...

Read More

KBI Biopharma Acquires Biologics Operations in Colorado

RESEARCH TRIANGLE PARK, NC– KBI Biopharma, Inc. (KBI) has signed an agreement with Merck & Co., Inc. (known as Merck in the United States and Canada)...

Read More

KBI Biopharma wins 2015 CMO Leadership Award

KBI Biopharma is honored to have been recognized as a winner of a 2015 CMO Leadership Award by Life Science Leader Magazine! This award was based on...

Read More

A Comparison of Multimodal Chromatography Resin | Case Study

Mixed Mode Chromatography & KBI's mAB Purification Platform

Read More

How KBI Helps Academic/Research Institutions

Every day, academic and research institutions generate massive amounts of data that increase our knowledge about disease and potential therapies. As...

Read More

Never Miss Another Update! 

Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.